GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case - Finance news and analysis from Global Banking & Finance Review
Finance

Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case 

Published by Global Banking & Finance Review

Posted on August 5, 2026

1 min read

· Last updated: August 5, 2026

Add as preferred source on Google
Finance Pharmaceuticals Legal Markets

Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case

Details of the Dutch Court Ruling on Semaglutide Patent

Background of the Case

STOCKHOLM, Aug 5 (Reuters) - Novo Nordisk said on Wednesday it had won a preliminary injunction against Ceban Ziekenhuisfarmacie from a district court in the Netherlands in a patent infringement case involving a compounded semaglutide nasal spray. 

Semaglutide and Its Significance

Semaglutide is the active ingredient in Novo Nordisk's weight-loss drug Wegovy. 

Court Findings and Orders

Infringement of Supplementary Protection Certificate

"The Court found that Ceban infringed Novo Nordisk's supplementary protection certificate (SPC) covering semaglutide," the Danish drugmaker said in a statement. 

Actions Ordered by the Court

Cease and Desist Orders

It said the court ordered Dutch firm Ceban to cease the infringing activities, remove product listings, disclose supply chain information, and reimburse Novo Nordisk's legal costs.

(Reporting by Anna Ringstrom, editing by Elviira Luoma)

Key Takeaways

  • The Dutch court’s injunction, granted August 5, 2026, prevents Ceban Ziekenhuisfarmacie B.V. from producing or distributing a compounded semaglutide nasal spray over patent concerns, reinforcing Novo Nordisk’s enforcement of its GLP‑1 drug patents in Europe.
  • This injunction comes amid a broader wave of litigation by Novo Nordisk, including recent U.S. cases against compounding pharmacies and telehealth outfits like Hims & Hers, highlighting the company’s global push to curb unauthorized semaglutide formulations (novonordisk.com).
  • The ruling reflects judicial support for patent holders in the semaglutide space, as Novo Nordisk continues securing injunctions and exclusivity protections, such as in Mexico and the UK, to shield its obesity and diabetes therapies from generic or counterfeit competition (apnews.com).

References

Frequently Asked Questions

What was the outcome of Novo Nordisk's patent case in the Netherlands?
Novo Nordisk won a preliminary injunction against Ceban Ziekenhuisfarmacie B.V. for patent infringement.
Which product was involved in the patent infringement case?
The case involved a compounded semaglutide nasal spray.
Who was the defendant in the Dutch patent case?
Ceban Ziekenhuisfarmacie B.V. was the defendant.
Which court issued the preliminary injunction in the patent case?
A district court in the Netherlands issued the injunction.

Tags

Related Articles

Image for Italy to handle Monte Paschi stake without interfering with M&A moves

Italy to handle Monte Paschi stake without interfering with M&A moves

Image for Anthropic to build in-house chip design team for Claude, hire engineers

Anthropic to build in-house chip design team for Claude, hire engineers

Image for GlobalFoundries tops second quarter estimates on AI chip demand

GlobalFoundries tops second quarter estimates on AI chip demand

Image for Surge in Black Sea attacks adds to strain on global commodity flows

Surge in Black Sea attacks adds to strain on global commodity flows

Image for Lilly's Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk

Lilly's Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk

Image for Analysis-Glencore's Australia listing taps mining-friendly capital for copper, M&A ambitions

Analysis-Glencore's Australia listing taps mining-friendly capital for copper, M&A ambitions

More from Finance

Explore more articles in the Finance category

Image for CPC oil loadings falter over safety issues and tanker shortages
CPC oil loadings falter over safety issues and tanker shortages
Image for France's drone production shifts from policy ambition to factory floor
France's drone production shifts from policy ambition to factory floor
Image for Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
Image for Activist investor Saba reveals exposure in UK's Unite Group
Activist investor Saba reveals exposure in UK's Unite Group
Image for Flutter appoints company veteran Taylor as CEO as Jackson to step down
Flutter appoints company veteran Taylor as CEO as Jackson to step down
Image for ECB says investment shift towards AI helps ease drag of uncertainty on euro zone growth 
ECB says investment shift towards AI helps ease drag of uncertainty on euro zone growth 
Image for Italy's Ducati to invest €121 million on R&D and innovation
Italy's Ducati to invest €121 million on R&D and innovation
Image for Sterling edges up; UK service sector activity improves 
Sterling edges up; UK service sector activity improves 
Image for Glencore's energy trading profits soar on Iran war 
Glencore's energy trading profits soar on Iran war 
Image for Prudential slides after report on China offshore insurance tax
Prudential slides after report on China offshore insurance tax
Image for What Are Your Options for Making a Car Finance Complaint?
What Are Your Options for Making a Car Finance Complaint?
Image for Michael Kors parent Capri lowers annual revenue forecast
Michael Kors parent Capri lowers annual revenue forecast
View All Finance Posts